BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32945345)

  • 21. LncRNA LINC00313 Knockdown Inhibits Tumorigenesis and Metastasis in Human Osteosarcoma by Upregulating FOSL2 through Sponging miR-342-3p.
    Chen H; Wahafu P; Wang L; Chen X
    Yonsei Med J; 2020 May; 61(5):359-370. PubMed ID: 32390359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.
    Yao H; Hou G; Wang QY; Xu WB; Zhao HQ; Xu YC
    Int J Oncol; 2020 Jan; 56(1):85-100. PubMed ID: 31746422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC00665 Facilitates the Malignant Processes of Osteosarcoma by Increasing the RAP1B Expression via Sponging miR-708 and miR-142-5p.
    Wang L; Song X; Yu L; Liu B; Ma J; Yang W
    Anal Cell Pathol (Amst); 2021; 2021():5525711. PubMed ID: 34306997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC00467 facilitates osteosarcoma progression by sponging miR‑217 to regulate KPNA4 expression.
    Yan J; Fang T; Zhang M; Zhou Q
    Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33537823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating the miR-221/ARHI Pathway.
    Ye K; Wang S; Zhang H; Han H; Ma B; Nan W
    J Cell Biochem; 2017 Dec; 118(12):4772-4781. PubMed ID: 28519068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
    Cui H; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma.
    Zhang Z; Zhang M; Chen Q; Zhang Q
    Cancer Gene Ther; 2017 Feb; 24(2):83-88. PubMed ID: 28186090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis.
    Zhou Y; Yin L; Li H; Liu LH; Xiao T
    Cancer Biol Ther; 2019; 20(8):1141-1148. PubMed ID: 30975024
    [No Abstract]   [Full Text] [Related]  

  • 33. SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma.
    Zhao W; Li L
    Pathol Res Pract; 2019 Mar; 215(3):439-445. PubMed ID: 30554864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
    Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
    J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis.
    Li C; Wang F; Wei B; Wang L; Kong D
    Biochem Biophys Res Commun; 2019 Jun; 514(3):1017-1022. PubMed ID: 31092328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
    Li Z; Tang Y; Xing W; Dong W; Wang Z
    Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NEAT1 induces osteosarcoma development by modulating the miR-339-5p/TGF-β1 pathway.
    Zhang L; Lu XQ; Zhou XQ; Liu QB; Chen L; Cai F
    J Cell Physiol; 2019 Apr; 234(4):5097-5105. PubMed ID: 30203547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of lncRNA HULC inhibits proliferation, migration, invasion, and promotes apoptosis by sponging miR-122 in osteosarcoma.
    Kong D; Wang Y
    J Cell Biochem; 2018 Jan; 119(1):1050-1061. PubMed ID: 28688193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.